Should I Buy AMCR? AMCR 2026 Analysis

Should You Buy Amcor PLC (AMCR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

48.170

1 Day change

2.97%

52 Week Range

52.250

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: price (45.46) is pushing into nearby resistance (R2 ~45.85) with limited upside implied by the most relevant new Street target (MS PT $46).
Short-term momentum is positive, but risk/reward is unattractive at this level; a better entry is on a pullback toward ~43.5 (pivot) or after a clean breakout above ~45.85 with follow-through.
Sentiment from options is bullish-leaning, but overall conviction is muted (low volume vs average), and fundamentals show margin/EPS pressure despite acquisition-driven revenue growth.
Intellectia Proprietary Trading Signals: No signal on given stock today (no AI Stock Picker, no SwingMax).

Technical Analysis

Trend/Momentum: MACD histogram at +0.1 and expanding indicates bullish momentum building.
RSI: RSI(6) ~65.6 (upper-neutral) suggests strength but getting closer to “crowded” territory; less attractive for a fresh chase.
Moving averages: Converging MAs = transition/indecision phase; price can move sharply, but confirmation matters.
Levels:
- Support: 43.52 (pivot), then 42.08 (S1)
- Resistance: 44.96 (R1, now essentially reclaimed), then 45.85 (R2, immediate ceiling)
Pattern/forward bias from similar setups: modest next-week upside (+0.72%) but negative next-month bias (-3.31%), arguing against buying at the top of the range.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: OI put/call 0.8 = slightly call-tilted; volume put/call 0.15 = strongly call-skewed day-of flow (bullish).
Activity: Today’s option volume is ~46.9% of the 30-day average (not a high-conviction spike).
Volatility: IV30 ~27.9 vs HV ~22.2 (options pricing in above-realized movement); IV percentile ~58 (mid-high), not extreme.

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings catalyst: Q2 results delivered a non-GAAP EPS beat (reported vs expectations) which typically supports near-term momentum.
- Acquisition narrative: Berry acquisition integration synergies described as on track; continued synergy realization/deleveraging is a medium-term support.
- Revenue growth headline: Q2 revenue up ~68% YoY (largely acquisition-driven) keeps the “scale + synergy” story alive.

Neutral/Negative Catalysts

- Quality of growth: Revenue missed expectations and appears heavily acquisition-driven rather than organic.
- Profitability pressure: Gross margin down materially (16.43, -14.96% YoY) and EPS down (-32.14% YoY) despite higher revenue—signals integration/mix/cost headwinds.
- Analyst pushback on volumes: Morgan Stanley cites negative organic volume momentum and cut PT to ~$46 (near current), capping near-term upside.
- Positioning/flow: Hedge funds and insiders show neutral recent activity—no strong “smart money” tailwind.

Financial Performance

Latest quarter: 2026/Q2.
Revenue: $5.449B (+68.13% YoY), primarily boosted by acquired sales (Berry acquisition impact).
Net income: $177M (+8.59% YoY) improved modestly versus the revenue surge.
EPS: 0.38 (-32.14% YoY), indicating dilution/integration costs or margin compression outweighing top-line growth.
Gross margin: 16.43 (-14.96% YoY), a clear negative trend that limits how much investors typically pay for the story right now.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: mixed but leaning cautious at the margin.
- 2026-01-28 Morgan Stanley downgraded to Equal Weight (from Overweight) and cut PT to $46 (from $57.50) on negative organic volume momentum (key near-term headwind).
- 2026-01-06 Truist maintained Buy and raised PT to $12 (from $11).
- 2026-01-05 BofA maintained Buy but lowered PT to $9.70 (from $10.30).
- 2026-01-07 Baird upgraded to Outperform with PT $10.
Wall Street pros view: synergy capture + deleveraging path + “attractive valuation” narrative.
Wall Street cons view: weak organic volume/mixed demand backdrop and profitability/margin pressure; the most relevant current target in the dataset ($46) suggests limited upside from 45.46.

7 Analyst Rating

Wall Street analysts forecast AMCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMCR is 10.72 USD with a low forecast of 9 USD and a high forecast of 13.6 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

2 Hold

0 Sell

Moderate Buy

Current: 46.780

Low

Averages

10.72

High

13.6

Current: 46.780

Low

Averages

10.72

High

13.6

Baird

Outperform

maintain

$50 -> $54

AI Analysis

2026-02-04

New

Reason

Baird

Price Target

$50 -> $54

AI Analysis

2026-02-04

New

maintain

Outperform

Reason

Baird raised the firm's price target on Amcor to $54 from $50 and keeps an Outperform rating on the shares. The firm updated its model following Q4 results and said it remains a top pick.

BofA

Buy

maintain

$56

2026-02-04

New

Reason

BofA

Price Target

$56

2026-02-04

New

maintain

Buy

Reason

BofA raised the firm's price target on Amcor to $56 from $48.40 and keeps a Buy rating on the shares. Following the fiscal Q2 report, the firm's FY26 and FY27 EPS forecasts move to $4.00 and $4.30 from $4.06 and $4.34, respectively.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AMCR

Unlock Now

AMCR Should I Buy

AMCR Should I Buy

Should You Buy Amcor PLC (AMCR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch